Boron Clusters - A New Entity for DNA-Oligonucleotide Modification

European Journal of Organic Chemistry

Volumn , Issue 23, 2003, Pages 4489-4500

  Lesnikowski, Zbigniew J ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

Antisense agents; Carboranes; DNA; Nucleosides; Oligonucleotides

Indexed keywords

5 (2 CARBORAN 1 YL) 2' DEOXYURIDINE; BORON DERIVATIVE; CARBORANE DERIVATIVE; DEOXYURIDINE DERIVATIVE; DICARBA 2 DODECABORANE; DNA; NUCLEIC ACID; NUCLEOTIDE; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ANTISENSE OLIGONUCLEOTIDE THERAPY; BIOCHEMISTRY; DIAGNOSTIC PROCEDURE; DNA MODIFICATION; MOLECULAR BIOLOGY; NEUTRON CAPTURE THERAPY; PHYSICAL CHEMISTRY; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; THERAPY;

EID: 0344738572     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejoc.200300259     Document Type: Short Survey

References (80)

1. S. Agrawal (Ed.), Methods in Molecular Biology, Vol. 20, Protocols for Oligonucleotides and Analogs. Synthesis and Properties, Humana Press Inc., Totowa, NJ, 1993.
2. U. Reischl (Ed.), Molecular diagnosis of Infectious Diseases, Humana Press Inc., Totowa, N. J., 1998.
3. G. H. Keller, M. M. Manak, DNA Probes. Background, applications and procedures, M Stockton Press, New York, N. Y., 1993.
4. S. Agrawal (Ed.), Antisense Therapeutics, Humana Press Inc., Totowa, NJ, 1996.
5. N. C. Seeman and 21 co-authors, Nanotechnology 1998, 9, 257-273.
6. C. M. Niemeyer, Angew. Chem. Int. Ed. Engl. 1997, 36, 585-587.
7. G. Paun, G. Rozenverg, A. Salomaa, DNA Computing. New Computing Paradigms, Springer, Heidelberg, Germany, 1998.
8. S. Agrawal (Ed.), Methods in Molecular Biology, Vol. 26. Protocols for Oligonucleotide Conjugates. Synthesis and Analytical Techniques, Totowa, NJ., Humana Press Inc., 1994.
9. R. P. Iyer, A. Roland, W. Zhou, K. Ghosh, Curr. Opin. Mol. Ther. 1999, 1, 344-358.
10. J. Micklefield, Cur. Med. Chem. 2001, 8, 1157-1179.
11. Z. J. Lesnikowski, R. F. Schinazi, J. Org. Chem. 1993, 58, 6531-6534.
12. Z. J. Lesnikowski, J. Shi, R. F. Schinazi, J. Organomet. Chem. 1999, 581, 156-169.
13. S. Verma, F. Eckstein, Modified oligonucleotides: Synthesis and strategy for users, Ann. Rev. Biochem. 1998, 67, 99-134.
14. A. Sood, B. R. Shaw, B. F. Spielvogel, J. Am. Chem. Soc. 1990, 112, 9000-9001.
15. Yao-Quan Chen, Fu-Cheng Qu, Yi-Bing Zhang, Tetrahedron Lett. 1995, 36, 745-748.
16. Jiancun Zhang, T. Terhorst, M. D. Matteucci, Tetrahedron Lett. 1997, 38, 4957-4960.
17. D. S. Sergueev, Z. A. Sergueeva, B. R. Shaw, Nucl. Nucl. & Nucl. Acids 2001, 20, 789-795.
18. H. A. Brummel, M. H. Caruthers, Tetrahedron Lett. 2002, 43, 749-751.
19. A. Sood, B. F. Spielvogel, B. R. Shaw, J. Am. Chem. Soc. 1989, 11, 9234-9235.
20. H. Li, K. Porter, F. Huang, B. R. Shaw, Nucl. Acids Res. 1995, 23, 4495-4501.
21. B. R. Shaw, J. Madison, A. Sood, B. F. Spielvogel, in: Methods in Molecular Biology Series, Vol. 20: Protocols for Oligonucleotides and Analogs (Ed.: S. Agrawal), Humana Press Inc., Totowa, NJ, 1993, p. 225-243.
22. Z. J. Lesnikowski, R. F. Schinazi, Pol. J. Chem. 1995, 69, 827-840.
23. Z. J. Lesnikowski, R. F. Schinazi, Nucl. Nucl. 1998, 17, 635-648.
24. V. Rait, D. Sergueev, J. Summers, K. Z. He, F. Q. Huang, B. Krzyzanowska, B. R. Shaw, Nucl. Nucl. 1999, 18, 1379-1380.
25. B. R. Shaw, D. Sergueev, K. Z. He, K. Porter, J. Summers, Z. Sergueeva, V. Rait, Antisense Technol., PT A 2000, 313, 226-257.
26. J. S. Summers, B. R. Shaw, Curr. Med. Chem. 2001, 8, 1147-1155.
27. Z. J. Lesnikowski, G. Fulcrand-El Kattan, R. M. Lloyd, Jr., R. F. Schinazi, Sulfur Silicon 1996, 109-110, 385-388.
28. R. R. Kane, C. S. Lee, K. Drechsel, M. F. Hawthorne, J. Org. Chem. 1993, 58, 3227-3228.
29. R. R. Kane, K. Drechsel, M. F. Hawthorne, J. Am. Chem. Soc. 1993, 115, 8853-8854.
30. [40]
31. R. R. Kane, R. H. Pak, M. F. Hawthorne, J. Org. Chem. 1993, 58, 991-992.
32. C. J. Chen, R. R. Kane, F. J. Primus, G. Szalai, M. F. Hawthorne, J. E. Shively, Bioconjugate Chem. 1994, 5, 557-564.
33. S. Sjöberg, J. Carlsson, H. Ghaneolhosseini, L. Hedda, T. Hartman, J. Malmquist, C. Naeslund, P. Olsson, W. Tjarks, J. Neuro-Oncol. 1997, 33, 41-52.
34. A. Varadarajan, M. F. Hawthorne, Bioconjugate Chem. 1991, 2, 242-253.
35. W. Tjarks, A. K. M. Anisuzzaman, L. Liu, A. H. Soloway, R. F. Barth, D. J. Perkins, D. M. Adams, J. Med. Chem. 1992, 35, 1628-1633.
36. N. M. Goudgaon, G. Fulcrand-El Kattan, R. F. Schinazi, Nucl. Nucl. 1994, 13, 849-880, and references cited therein.
37. W. Tjarks, J. Organomet. Chem. 2000, 614, 37-47.
38. D. P. Kelly, S. A. Bateman, R. F. Martin, M. E. Reum, M. Rose, R. D. Whittaker, Aust. J. Chem. 1994, 47, 1751-1771.
39. Y. Yamamoto, J. Cai, H. Nakamura, N. Sadayori, N. Asao, H. Nemoto, J. Org. Chem. 1995, 60, 3352-3357.
40. M. A. Rosental, B. Kavar, J. S. Hill, D. J. Morgan, R. L. Nation, M. Daniel, G. Varigos, M. Searle, S. S. Stylli, R. L. Basser, S. Uren, H. Geldard, M. D. Green, S. B. Kahl, A. H. Kaye, J. Clin. Oncol. 2001, 19, 519-524.
41. J. Casanova (Ed.), The Borane, Carborane, Carbocation Continuum, John Wiley & Sons Inc., New York, 1998.
42. R. E. Williams, Chem. Rev. 1992, 92, 177-207.
43. R. B. King, Chem. Rev. 2001, 101, 1119-1152.
44. Chem. Rev. 92 (1992), special issue on boranes and heteroboranes.
45. V. I. Bregadze, Chem. Rev. 1992, 92, 209-223.
46. T. Vondrak, J. Plesek, S. Hermanek, B. Stibr, Polyhedron 1989, 8, 805-811.
47. K. Hermansson, M. Wojcik, S. Sjoberg, Inorg. Chem. 1999, 38, 6039.
48. A. J. Lunato, J. Wang, J. E. Woollard, A. K. M. Anisuzzaman, W. Ji, F-G. Rong, S. Ikeda, A. H. Soloway, S. Eriksson, D. H. Ives, T. E. Blue, W. Tjarks, J. Med. Chem. 1999, 42, 3378-3389.
49. K. Yamamoto, Y. Endo, Bioorg. Med. Chem. Lett. 2001, 11, 2389-2392.
50. D. R. Lide (Editor-in Chief), Handbook of Chemistry and Physics, 77th ed., CRC Press, Boca Raton, Fl., 1996.
51. Z. J. Lesnikowski, R. M. Lloyd Jr., R. F. Schinazi, Nucl. Nucl. 1997, 16, 1503-1505.
52. G. Fulcrand-El Kattan, Z. J. Lesnikowski, S. Yao, F. Tanious, W. D. Wilson, R. F. Shinazi, J. Am. Chem. Soc. 1994, 116, 7494-7501.
53. A. B. Olejniczak, M. Koziolkiewicz, Z. J. Lesnikowski, Antisense Nucl. Acid Drug Develop. 2002, 12, 79-94.
54. C. B. Reese, Tetrahedron 1978, 34, 3143-3179.
55. A. K. Bhattacharya, G. Thyagarajan, Chem. Rev. 1981, 81, 415-430.
56. T. L. Heying, J. W. Ager Jr., S. L. Clark, D. J. Mangold, H. L. Goldstein, M. Hillman, R. J. Polak, J. W. Szymanski, Inorg. Chem. 1963, 2, 1089-1092.
57. G. W. Daub, E. E. van Tamelen, J. Am. Chem. Soc. 1977, 99, 3526-3525.
58. S. L. Beaucage, R. P. Iyer, Tetrahedron 1992, 48, 2223-2311.
59. P. Neuner, R. Cortese, P. Monaci, Nucl. Acids Res. 1998, 1223-1227.
60. A. L. Kayushin, M. D. Korosteleva, A. I. Miroshnikov, W. Kosch, D. Zubov, N. Piel, Nucl. Acids Res. 1996, 3748-3755.
61. R. P. Mauritz, C. Meier, E. Uhlmann, Nucl. Nucl. 1997, 1209-1212.
62. T. Atkinson, M. Smith, in: Oligonucleotide Synthesis: A Practical Approach (Ed.: M. Gait), (IRL, Oxford), 1984, pp. 35-81.
63. S. L. Beaucage, in: Methods in Molecular Biology, Vol. 20, Protocols for Oligonucleotides and Analogs. Synthesis and Properties (Ed.: S. Agrawal), Humana Press Inc., Totowa, NJ, 1993, pp. 33-61.
64. For examples of other boron containing nucleoside phosphates see references [65] {carboranyl bis(adenosine diphosphate)} and [66, 67] {3′- or 5′-[diethylphosphite(cyano, carboxy, or carbamoyl)boranoldeoxynucleosides}.
65. K. Vyakaranam, G. Rana, S. Delaney, S. Ledger, N. S. Hosmane, Inorg. Chem. Commun. 2003, 6, 654.
66. K. Vyakaranam, G. Rana, B. F. Spielvogel, J. M. Maguire, N. S. Hosmane, Nucl. Nucl. Nucl. Acids 2002, 8-9, 581.
67. K. Vyakaranam, G. Rana, B. F. Spielvogel, N. S. Hosmane, Inorg. Chem. Commun. 2001, 4, 629.
68. Y. Yamamoto, T. Seko, H. Nakamura, H. Nemeto, Heteroatom Chem. 1992, 3, 239-244.
69. R. F. Schinazi, N. M. Goudgaon, G. Fulcrand, Y. El Kattan, Z. J. Lesnikowski, J. Moravek, D. C. Liotta, Intl. J. Radiation Oncol. Biol. Phys. 1994, 28, 1113-1120.
70. W. Tjarks, A. K. M. Anisuzzaman, L. Liu, A. H. Soloway, R. F. Barth, D. J. Perkins, D. A. Adams, J. Med. Chem. 1992, 35, 1628-1633.
71. D. Wagner, J. P. H. Verheyden, J. G. Moffat, J. Org. Chem. 1974, 39, 24-30.
72. A. B. Olejniczak, M. Kwiatkowski, A. Semenuk, Z. J. Lesnikowski, J. Organomet. Chem. manuscript accepted.
73. Applied Biosystems USER Bulletin No. 43, Applied Biosystems, Foster City, CA, 1987.
74. Z. J. Lesnikowski, G. Fulcrand-El Kattan, R. M. Lloyd, R. M. A. Juodawlkis, R. F. Schinazi, Biochemistry 1996, 35, 5741-5746.
75. M. F. Hawthorne, D. C. Young, P. M. Garret, D. A Owen, S. G. Rchwerin, F. N. Tebbe, P. A. Wagner, J. Am. Chem. Soc. 1968, 90, 862-868.
76. R. F. Schinazi, Z. J. Lesnikowski, G. Fulcrand-El Kattan, W. D. Wilson, Carboranyl Oligonucleotides for Antisense Technology and Boron Neutron Capture Therapy of Cancers, American Chemical Society Symposium Series, Vol. 580, Carbohydrate Modifications in Antisense Research, Sanghvi YS, Cook PD), chapter 11, 1994, pp. 169-182.
77. Y. Endo, T. Iijima, Y. Yamakoshi, H. Fukasawa, C. Miyaura, M. Inada, A. Kubo, A. Itai, Chem. Biol. 2001, 8, 341-355.
78. J. C. Bologna, E. Vives, J. L. Imbach, F. Morvan, Antisense Nucl. Acid Drug Develop. 2002, 12, 33-41.
79. A. B. Olejniczak, Z. J. Lesnikowski, in: Research and Development in Neutron Capture Therapy, Proc. 10th International Congress on Neutron Capture Therapy, Essen, Germany, September, 8-13, 2002 (Eds.: W. Sauerwein, R. Moss, A. Wittig), Monduzzi Editore, Bologna, Italy; pp. 53-57.
80. J. F. Valliant, K. J. Guenther, A. S. King, P. Morel, P. Schaffer, O. O. Sogbein, K. A. Coordin, Chem. Rev. 2002, 232, 173-230.